LexaGene Holdings Management
Management criteria checks 3/4
LexaGene Holdings' CEO is Jack Regan, appointed in Oct 2016, has a tenure of 6.58 years. total yearly compensation is $482.44K, comprised of 70.2% salary and 29.8% bonuses, including company stock and options. directly owns 4.3% of the company’s shares, worth €435.92K. The average tenure of the management team and the board of directors is 5.8 years and 4.3 years respectively.
Key information
Jack Regan
Chief executive officer
US$482.4k
Total compensation
CEO salary percentage | 70.2% |
CEO tenure | 6.6yrs |
CEO ownership | 4.3% |
Management average tenure | 5.8yrs |
Board average tenure | 4.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Nov 30 2022 | n/a | n/a | -US$9m |
Aug 31 2022 | n/a | n/a | -US$10m |
May 31 2022 | n/a | n/a | -US$10m |
Feb 28 2022 | US$482k | US$338k | -US$11m |
Nov 30 2021 | n/a | n/a | -US$11m |
Aug 31 2021 | n/a | n/a | -US$11m |
May 31 2021 | n/a | n/a | -US$11m |
Feb 28 2021 | US$466k | US$250k | -US$10m |
Nov 30 2020 | n/a | n/a | -US$9m |
Aug 31 2020 | n/a | n/a | -US$9m |
May 31 2020 | n/a | n/a | -US$8m |
Feb 29 2020 | US$375k | US$250k | -US$7m |
Nov 30 2019 | n/a | n/a | -US$8m |
Aug 31 2019 | n/a | n/a | -US$8m |
May 31 2019 | n/a | n/a | -US$8m |
Feb 28 2019 | US$300k | US$240k | -US$8m |
Nov 30 2018 | n/a | n/a | -US$7m |
Aug 31 2018 | n/a | n/a | -US$7m |
May 31 2018 | n/a | n/a | -US$5m |
Feb 28 2018 | US$200k | US$200k | -US$4m |
Nov 30 2017 | n/a | n/a | -US$3m |
Aug 31 2017 | n/a | n/a | -US$6m |
May 31 2017 | n/a | n/a | -US$5m |
Feb 28 2017 | US$180k | US$180k | -US$4m |
Compensation vs Market: Jack's total compensation ($USD482.44K) is about average for companies of similar size in the German market ($USD418.12K).
Compensation vs Earnings: Jack's compensation has increased whilst the company is unprofitable.
CEO
Jack Regan (49 yo)
6.6yrs
Tenure
US$482,437
Compensation
Dr. John F. Regan, also known as Jack, is the Founder of LexaGene Holdings Inc. since 2016 and has been its Chairman of the Board since September 12, 2017 and its Chief Executive Officer and Director since...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 6.6yrs | US$482.44k | 4.3% $ 435.9k | |
CFO, Treasurer & Corporate Secretary | 5.2yrs | US$344.52k | 0.11% $ 11.0k | |
Chief Operating Officer | 2.8yrs | US$268.40k | 0.28% $ 28.6k | |
Vice President of Corporate Development | 6.5yrs | no data | no data | |
Director of Corporate Marketing | no data | no data | no data | |
Vice President of Capital Markets | no data | no data | no data |
5.8yrs
Average Tenure
54yo
Average Age
Experienced Management: 5XS2's management team is seasoned and experienced (5.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 6.6yrs | US$482.44k | 4.3% $ 435.9k | |
Independent Director | 4.9yrs | US$98.81k | 0.0073% $ 741.3 | |
Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
Member of Scientific Advisory Board | 4.1yrs | no data | no data | |
Independent Director | 6.6yrs | US$137.68k | 0% $ 0 | |
Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
Member of Scientific Advisory Board | 2.7yrs | no data | no data | |
Independent Director | 2.3yrs | US$164.83k | 0% $ 0 | |
Independent Director | 1.5yrs | US$92.35k | 0% $ 0 |
4.3yrs
Average Tenure
62yo
Average Age
Experienced Board: 5XS2's board of directors are considered experienced (4.3 years average tenure).